Glucosylceramide synthase inhibitors
The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in 5 combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
18.02.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in 5 combination with enzyme replacement therapy, cystic disease and for the treatment of cancer. |
---|---|
Bibliography: | Application Number: AU20190222801 |